Chemours CC Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$409M-6.2% | -$385M-10.3% | -$349M+17.3% | -$422M-1,663% | $27M-68.6% | ||
| $331M-2.6% | $340M+2.1% | $333M+2.1% | $326M+5.5% | $309M+5.8% | ||
| $23M+9.5% | $21M+5.0% | $20M0.0% | $20M+5.3% | $19M+26.7% | ||
| —— | —— | —— | $79M+268% | -$47M-42.4% | ||
| $11M0.0% | $11M-8.3% | $12M0.0% | $12M0.0% | $12M0.0% | ||
| $32M0.0% | $32M+10.3% | $29M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $55M+1,275% | ||
| -$39M+44.3% | -$70M-192% | $76M-11.6% | $86M+6.2% | $81M-17.3% | ||
| $263M-6.1% | $280M+11.6% | $251M-3.8% | $261M+944% | $25M+127% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $5M-16.7% | ||
| —— | —— | —— | —— | -$750K+25.0% | ||
| -$140M-32.1% | -$106M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $332M+25.8% | $264M— | —— | —— | —— | ||
| $178M-16.4% | $213M-23.1% | $277M-11.2% | $312M-8.8% | $342M-5.0% | ||
| —— | —— | —— | —— | —— | ||
| -$164M+20.4% | -$206M+23.7% | -$270M+12.9% | -$310M+8.3% | -$338M+4.2% | ||
| $54M-30.8% | $78M-21.2% | $99M-20.2% | $124M-16.2% | $148M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $8M-11.1% | ||
| $14M0.0% | $14M-6.7% | $15M+15.4% | $13M+8.3% | $12M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$88M+30.2% | -$126M— | —— | —— | —— | ||
| $21M-27.6% | $29M+263% | $8M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $251M-1.6% | $255M-1.5% | $259M-1.5% | $263M-1.5% | ||
| —— | $74M-2.6% | $76M-2.6% | $78M-2.5% | $80M-2.4% | ||
| $11M0.0% | $11M-8.3% | $12M0.0% | $12M0.0% | $12M0.0% | ||
| —— | —— | —— | $13M+8.3% | $12M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$140M-32.1% | -$106M— | —— | —— | —— | ||
| $32M-72.2% | $115M-14.8% | $135M-25.8% | $182M— | —— | ||
| $14M+567% | -$3M-105% | $56M— | —— | —— | ||
| $263M-6.1% | $280M+11.6% | $251M-3.8% | $261M+944% | $25M+127% | ||
| $32M0.0% | $32M+10.3% | $29M— | —— | —— | ||
| —— | —— | —— | —— | -$2M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $14M0.0% | $14M-6.7% | $15M+15.4% | $13M+8.3% | $12M0.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $67M-23.9% | $88M-4.3% | $92M-2.1% | $94M-6.0% | $100M-2.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $69M-13.8% | $80M-11.1% | $90M-3.2% | $93M0.0% | $93M0.0% | ||
| $1.47B+86.5% | $787M+32.0% | $596M0.0% | $596M+20.4% | $495M+1.0% | ||
| —— | $74M-2.6% | $76M-2.6% | $78M-2.5% | $80M-2.4% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Chemours's cash flow data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.